Literature DB >> 33745119

Cost-effectiveness of preferred fluids versus electrolytes in pediatric gastroenteritis.

Myla E Moretti1,2, Wendy J Ungar3,4, Stephen B Freedman5, Suzanne Schuh6,7,8.   

Abstract

BACKGROUND: While electrolyte maintenance solution is recommended and commonly used in pediatric gastroenteritis, it can be more costly and less palatable than preferred fluids such as apple juice.
OBJECTIVE: To assess the incremental cost-effectiveness of apple juice/preferred fluids versus electrolyte maintenance solution in reducing treatment failures in children in an emergency department from societal and health care perspectives.
METHODS: A probabilistic cost-effectiveness analysis was performed using clinical trial and chart data. All intervention, and direct and indirect costs were included, with a 14-day time horizon. Cost-effectiveness was examined by calculating the difference in mean number of treatment failures and mean cost/patient between treatment groups. The probabilistic point estimate and 95% confidence intervals for incremental costs and incremental effectiveness were determined.
RESULTS: The apple juice strategy was less costly than electrolytes with average per child savings of CAD $171 (95% CI $22 to $1097) from a societal perspective, and $147 (95% CI $23 to $1056) from a health care perspective. There were 0.08 fewer treatment failures per child (95% CI - 0.15 to - 0.02). The higher electrolyte maintenance solution cost was due to more frequent hospitalizations, ongoing care, and greater lost parental productivity due to additional medical visits.
CONCLUSION: Apple juice/preferred fluids strategy was dominant over electrolytes in the treatment of children with minimal dehydration secondary to acute gastroenteritis as this option yielded fewer treatment failures and a lower societal cost. Given the high prevalence of acute gastroenteritis, this approach may result in significant cost savings while leading to improved clinical outcomes.

Entities:  

Keywords:  Child health; Cost-effectiveness analysis; Gastroenteritis; Oral rehydration therapy

Year:  2021        PMID: 33745119     DOI: 10.1007/s43678-021-00108-9

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


  1 in total

1.  Barriers to use of oral rehydration therapy.

Authors:  E C Reis; J G Goepp; S Katz; M Santosham
Journal:  Pediatrics       Date:  1994-05       Impact factor: 7.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.